Boston Partners’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.9M Sell
518,159
-13,146
-2% -$530K 0.02% 383
2026
Q1
$17.8M Buy
531,305
+83,763
+19% +$3.51M 0.02% 385
2025
Q4
$20.8M Buy
+447,542
New +$16.4M 0.02% 368
2015
Q3
Sell
-85,842
Closed -$3.24M 728
2015
Q2
$3.24M Buy
85,842
+630
+0.7% +$23K ﹤0.01% 572
2015
Q1
$2.99M Sell
85,212
-7,220
-8% -$238K ﹤0.01% 576
2014
Q4
$3.06M Sell
92,432
-1,075
-1% -$33.2K ﹤0.01% 596
2014
Q3
$2.56M Buy
93,507
+2,060
+2% +$56.4K ﹤0.01% 606
2014
Q2
$2.63M Hold
91,447
﹤0.01% 603
2014
Q1
$2.62M Buy
91,447
+780
+0.9% +$21.3K ﹤0.01% 596
2013
Q4
$2.31M Sell
90,667
-865
-0.9% -$20.7K ﹤0.01% 604
2013
Q3
$2.17M Sell
91,532
-135,497
-60% -$3.02M 0.01% 593
2013
Q2
$4.67M Buy
+227,029
New +$4.19M 0.01% 488

Other funds holding OMCL

Boston Partners's OMCL Position: Q2 2026 in Review

Boston Partners reduced its Omnicell (OMCL) stake by 2.5% in Q2 2026, selling an estimated $530K and leaving 518,159 shares worth $21.9M. The position accounts for 0.02% of the portfolio, ranked #383.

Boston Partners first reported a position in OMCL in Q2 2013 and has held it in 12 quarters since. 307 funds tracked by Wall St. Rank hold OMCL as of Q2 2026.

  • Boston Partners held 518,159 shares of Omnicell worth $21.9M as of Q2 2026.
  • Boston Partners sold 13,146 Omnicell shares in Q2 2026, an estimated $530K.
  • Omnicell made up 0.02% of Boston Partners's portfolio in Q2 2026, its #383 holding.
  • Boston Partners first reported a position in Omnicell in Q2 2013 and has held it in 12 quarters since.
  • 307 funds tracked by Wall St. Rank held Omnicell as of Q2 2026.

Based on Boston Partners's 13F filing for Q2 2026, filed 4 Aug 2026.